Principal Financial Group’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.7K | Buy |
+10,382
| New | +$11.7K | ﹤0.01% | 2223 |
|
2024
Q3 | – | Sell |
-16,836
| Closed | -$39.2K | – | 2230 |
|
2024
Q2 | $39.2K | Sell |
16,836
-13,935
| -45% | -$32.5K | ﹤0.01% | 2301 |
|
2024
Q1 | $138K | Sell |
30,771
-3,842
| -11% | -$17.2K | ﹤0.01% | 2235 |
|
2023
Q4 | $111K | Sell |
34,613
-231,541
| -87% | -$743K | ﹤0.01% | 2260 |
|
2023
Q3 | $844K | Buy |
266,154
+4,531
| +2% | +$14.4K | ﹤0.01% | 1862 |
|
2023
Q2 | $1.3M | Buy |
261,623
+995
| +0.4% | +$4.95K | ﹤0.01% | 1810 |
|
2023
Q1 | $1.29M | Buy |
260,628
+9,769
| +4% | +$48.3K | ﹤0.01% | 1821 |
|
2022
Q4 | $1.58M | Buy |
250,859
+2,316
| +0.9% | +$14.6K | ﹤0.01% | 1802 |
|
2022
Q3 | $2.68M | Buy |
248,543
+7,260
| +3% | +$78.4K | ﹤0.01% | 1668 |
|
2022
Q2 | $2.75M | Buy |
241,283
+4,074
| +2% | +$46.4K | ﹤0.01% | 1734 |
|
2022
Q1 | $2.16M | Sell |
237,209
-908
| -0.4% | -$8.27K | ﹤0.01% | 1851 |
|
2021
Q4 | $3.55M | Buy |
238,117
+97,060
| +69% | +$1.45M | ﹤0.01% | 1763 |
|
2021
Q3 | $3.63M | Sell |
141,057
-878
| -0.6% | -$22.6K | ﹤0.01% | 1773 |
|
2021
Q2 | $3.7M | Buy |
141,935
+3,607
| +3% | +$94.1K | ﹤0.01% | 1786 |
|
2021
Q1 | $4.88M | Buy |
138,328
+13,726
| +11% | +$485K | ﹤0.01% | 1674 |
|
2020
Q4 | $3.15M | Buy |
124,602
+13,894
| +13% | +$351K | ﹤0.01% | 1695 |
|
2020
Q3 | $4.18M | Buy |
110,708
+2,611
| +2% | +$98.5K | ﹤0.01% | 1525 |
|
2020
Q2 | $4.63M | Sell |
108,097
-27,068
| -20% | -$1.16M | ﹤0.01% | 1460 |
|
2020
Q1 | $2.63M | Buy |
135,165
+752
| +0.6% | +$14.6K | ﹤0.01% | 1516 |
|
2019
Q4 | $3.49M | Sell |
134,413
-898
| -0.7% | -$23.3K | ﹤0.01% | 1623 |
|
2019
Q3 | $3.69M | Buy |
135,311
+146
| +0.1% | +$3.98K | ﹤0.01% | 1599 |
|
2019
Q2 | $3.63M | Buy |
135,165
+76,665
| +131% | +$2.06M | ﹤0.01% | 1618 |
|
2019
Q1 | $1.69M | Sell |
58,500
-5,800
| -9% | -$168K | ﹤0.01% | 1759 |
|
2018
Q4 | $1.73M | Buy |
+64,300
| New | +$1.73M | ﹤0.01% | 1739 |
|